We found that iNKT cells from patients with different forms of MS were able to respond to a potent stimulation, and they mainly produced Th1 and Th17 cytokines, such as TNF-α, IFN-γ, and IL-17. The gene discussed is IL17A; the disease is myeloid sarcoma.